| Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge M Law, T Maruyama, J Lewis, E Giang, AW Tarr, Z Stamataki, ... Nature medicine 14 (1), 25-27, 2008 | 675 | 2008 |
| Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies JM Timpe, Z Stamataki, A Jennings, K Hu, MJ Farquhar, HJ Harris, ... Hepatology 47 (1), 17-24, 2008 | 467 | 2008 |
| Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science PC Evans, GE Rainger, JC Mason, TJ Guzik, E Osto, Z Stamataki, D Neil, ... Cardiovascular research 116 (14), 2177-2184, 2020 | 443 | 2020 |
| COVID-19 and liver disease: mechanistic and clinical perspectives T Marjot, GJ Webb, AS Barritt IV, AM Moon, Z Stamataki, VW Wong, ... Nature reviews Gastroenterology & hepatology 18 (5), 348-364, 2021 | 356 | 2021 |
| Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost J Zhong, P Gastaminza, J Chung, Z Stamataki, M Isogawa, G Cheng, ... Journal of virology 80 (22), 11082-11093, 2006 | 280 | 2006 |
| Hepatitis C virus infects the endothelial cells of the blood-brain barrier NF Fletcher, GK Wilson, J Murray, K Hu, A Lewis, GM Reynolds, ... Gastroenterology 142 (3), 634-643. e6, 2012 | 277 | 2012 |
| Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics E Liaskou, HW Zimmermann, KK Li, YH Oo, S Suresh, Z Stamataki, ... Hepatology 57 (1), 385-398, 2013 | 269 | 2013 |
| Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity J Grove, T Huby, Z Stamataki, T Vanwolleghem, P Meuleman, M Farquhar, ... Journal of virology 81 (7), 3162-3169, 2007 | 207 | 2007 |
| MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure E Triantafyllou, OT Pop, LA Possamai, A Wilhelm, E Liaskou, ... Gut 67 (2), 333-347, 2018 | 188 | 2018 |
| Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium S Shetty, CJ Weston, YH Oo, N Westerlund, Z Stamataki, J Youster, ... The Journal of Immunology 186 (7), 4147-4155, 2011 | 174 | 2011 |
| Superinfection exclusion in cells infected with hepatitis C virus DM Tscherne, MJ Evans, T von Hahn, CT Jones, Z Stamataki, ... Journal of virology 81 (8), 3693-3703, 2007 | 174 | 2007 |
| Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies Z Stamataki, S Coates, MJ Evans, M Wininger, K Crawford, C Dong, ... Vaccine 25 (45), 7773-7784, 2007 | 112 | 2007 |
| Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells Z Stamataki, C Shannon-Lowe, J Shaw, D Mutimer, AB Rickinson, ... Blood, The Journal of the American Society of Hematology 113 (3), 585-593, 2009 | 99 | 2009 |
| A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration GK Wilson, CL Brimacombe, IA Rowe, GM Reynolds, NF Fletcher, ... Journal of hepatology 56 (4), 803-809, 2012 | 97 | 2012 |
| A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration GK Wilson, CL Brimacombe, IA Rowe, GM Reynolds, NF Fletcher, ... Journal of hepatology 56 (4), 803-809, 2012 | 97 | 2012 |
| Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics J Ast, A Arvaniti, NHF Fine, D Nasteska, FB Ashford, Z Stamataki, ... Nature Communications 11 (1), 467, 2020 | 89 | 2020 |
| Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains Z Stamataki, S Coates, S Abrignani, M Houghton, JA McKeating Journal of Infectious Diseases 204 (5), 811-813, 2011 | 72 | 2011 |
| Clearance of apoptotic cells by tissue epithelia: a putative role for hepatocytes in liver efferocytosis SP Davies, GM Reynolds, Z Stamataki Frontiers in immunology 9, 320864, 2018 | 66 | 2018 |
| Hepatitis C virus entry and neutralization Z Stamataki, J Grove, P Balfe, JA McKeating Clinics in liver disease 12 (3), 693-712, 2008 | 62 | 2008 |
| Cutting edge: the PI3K p110δ is required for down-regulation of Rag expression in immature B cells M Llorian, Z Stamataki, S Hill, M Turner, IL Mårtensson The Journal of Immunology 178 (4), 1981-1985, 2007 | 62 | 2007 |
